How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks

Go to News Site